WW INTERNATIONAL, INC.
WW International, which operates as Weight Watchers, offers weight management programs and related services to individual members, employers, payers and health plans. Its single reportable segment comprises Behavioral and Clinical businesses. Core provides digital subscriptions to weight management programs, app tools and a member community; Core+ adds unlimited coaching and workshops. Med+, available in the United States to clinically eligible members, combines behavioral offerings with access to clinicians, medication management and FDA-approved medications. Weight Watchers for Business offers Behavioral and Clinical services to organizations. The company makes money primarily through subscriptions, with some one-time payments for add-on services such as registered dietitian visits. Its programs include Points, GLP-1 Success, Diabetes and Menopause offerings, delivered through its app, workshops and clinical telehealth platform. WW International is headquartered in New York, NY.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $WW in the last 30 days.
See all $WW insider activity →WW International reported 3Q 2026 revenue of $152.9M, down 11.2% YoY, but swung to a net income of $15.11M. Behavioral subscriber decline drove revenue drop, while Clinical subscribers grew. EPS was $1.51. Lower marketing and admin expenses improved profitability.
WW INTERNATIONAL, INC. (WW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Weight Watchers Announces Third Quarter 2026 Results Revenue of $153 million; Clinical Subscription Revenue of $38 million, up 48% year-over-year 2.3 million Total End of Period Subscribers; 40% year-over-year Clinical End of Period Subscriber growth to 174 thousand
WeightWatchers (WW) reports earnings Thursday. Last quarter, revenue was $162.3M, down 14.2% YoY, beating EPS but missing EBITDA estimates. Analysts expect this quarter's revenue to decline 11.5% YoY. WW trades at $12.66, with an average price target of $27.50.
Over the past 7 days, AlphAI's AI scored 9 news stories mentioning WW (WW INTERNATIONAL, INC.). Coverage has skewed bearish: 0 bullish, 2 neutral, and 7 bearish.
Recent WW coverage spans earnings, market movers and macro economy.
Revenue fell 11.2% YoY and EPS turned positive, but both miss prior expectations.
Updated guidance may temper investor optimism after a surprise profit.
Ahead of the earnings print, the key trade is whether WW can sustain revenue momentum versus the expected double-digit YoY decline, and whether EBITDA weakness persists.
The announcement sets the date for the earnings release but provides no new financial data.
Negative near-term outlook as investors continue to treat GLP-1-led substitution as the dominant driver over partnership optimism.
AlphAI scores every news story that mentions WW with an AI model for sentiment and relevance, and aggregates insider trades from WW INTERNATIONAL, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
WW International reported 3Q 2026 revenue of $152.9M, down 11.2% YoY, but swung to a net income of $15.11M. Behavioral subscriber decline drove revenue drop, while Clinical subscribers grew. EPS was $1.51. Lower marketing and admin expenses improved profitability.
WW INTERNATIONAL, INC. (WW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Weight Watchers Announces Third Quarter 2026 Results Revenue of $153 million; Clinical Subscription Revenue of $38 million, up 48% year-over-year 2.3 million Total End of Period Subscribers; 40% year-over-year Clinical End of Period Subscriber growth to 174 thousand
WeightWatchers (WW) reports earnings Thursday. Last quarter, revenue was $162.3M, down 14.2% YoY, beating EPS but missing EBITDA estimates. Analysts expect this quarter's revenue to decline 11.5% YoY. WW trades at $12.66, with an average price target of $27.50.
Weight Watchers (WW) will release its Q3 2026 earnings before market open on Nov. 5, 2026, followed by a conference call at 8:30 a.m. ET. The webcast and replay will be available on the company's website. Weight Watchers is a global leader in weight management, offering science-backed programs and support.
Oxford Industries, iHeartMedia, AMC Networks, Xponential Fitness, and WeightWatchers shares fell due to a drop in consumer sentiment and higher Treasury yields. The LSEG/Ipsos index fell to 45.2 in October 2026, its lowest since 2011. WeightWatchers, down 58.4% YTD, was notably impacted by GLP-1 drug demand. Higher yields also pressured companies reliant on consumer financing.
H&R Block (HRB) beat earnings estimates and raised guidance, but its stock fell 1.4% to $46.03. Matthews (MATW) reported a 29.6% revenue decline, missing estimates, and its stock dropped 32.5% to $18.68. Service International (SCI) saw a 3.6% revenue increase, beating expectations, but its stock fell 8.5% to $78.37. WeightWatchers (WW) reported a 14.2% revenue decline, beating some estimates but missing others, and its stock dropped 6.5% to $14.41.
Service International (NYSE:SCI) reported Q2 revenue of $1.10B, up 3.6% YoY, beating estimates by 1.8%. Despite a strong quarter, its stock fell 9.7%. H&R Block (NYSE:HRB) also beat estimates, but its stock dropped 8.4%. Matthews (NASDAQ:MATW) missed estimates, with revenue down 29.6% YoY, and its stock fell 29.8%. The consumer discretionary sector saw average revenue growth of 0.3% YoY, with stocks down 13.8% since earnings reports.
WW International (WW) shares rose 8% after Northland initiated coverage with an Outperform rating and $25 target. The firm cited WW's turnaround strategy and partnerships as key to recovery. WW faced challenges from GLP-1 medications and debt, leading to a bankruptcy filing in May 2025. Analysts highlight strategic collaborations with Google, Eli Lilly, and Sam's Club as potential growth drivers.
WeightWatchers (WW) shares fell 10.3% due to declining demand for traditional diet programs amid rising use of GLP-1 weight-loss drugs. The drop follows a previous 6.4% decline, despite a partnership with Google Health Enterprise. WW stock is down 56.1% YTD, trading at $13.80, 60.5% below its 52-week high.
WW International stock rose 10.4% in pre-market trading after announcing a collaboration with Google Health Enterprise, integrating Google's wearable tech with Weight Watchers' wellness programs. The partnership targets the corporate health benefits market and follows a technical breakout above the 200-day moving average. Institutional investors have increased their stakes, with Cygnus Capital Advisors doubling its position and Bank of New York Mellon initiating a new stake.
